MK2 signaling: Lessons on tissue specificity in modulation of inflammation

Journal of Investigative Dermatology

Volumn 130, Issue 2, 2010, Pages 342-344

  Fyhrquist, Nanna ^a   Matikainen, Sampsa ^a   Lauerma, Antti ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 1BETA; MK2 ENZYME; PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CONTACT ALLERGY; INNATE IMMUNITY; NONHUMAN; NOTE; PRIORITY JOURNAL; SKIN INFLAMMATION; TISSUE SPECIFICITY;

EID: 75649133237     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.372     Document Type: Note

References (12)

1. Wu JP, Wang J, Abeywardane A et al. (2007) The discovery of carboline analogs as potent MAPKAP-K2 inhibitors. Bioorg Med Chem Lett 17:4664-4669
2. Anderson DR, Hegde S, Reinhard E et al. (2005) Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg Med Chem Lett 15:1587-1590
3. Anderson DR, Meyers MJ, Vernier WF et al. (2007) Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). J Med Chem 50:2647-2654
4. Badger AM, Bradbeer JN, Votta B et al. (1996) Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279:1453-1461
5. Dambach DM (2005) Potential adverse effects associated with inhibition of p38alpha/beta MAP kinases. Curr Topics Med Chem 5:929-939
6. Gaestel M, Kotlyarov A, Kracht M (2009) Targeting innate immunity protein kinase signalling in inflammation. Nat Rev Drug Discov 8:480-499
7. Gorska MM, Liang Q, Stafford SJ et al. (2007) MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation. J Exp Med 204:1637-1652
8. Kotlyarov A, Neininger A, Schubert C et al. (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1:94-97
9. Martinon F, Tschopp J (2005) NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26:447-454
10. Ronkina N, Kotlyarov A, Dittrich-Breiholz O et al. (2007) The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol Cell Biol 27:170-181
11. Schlapbach A, Feifel R, Hawtin S et al. (2008) Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activity. Bioorg Med Chem Lett 18:6142-6146
12. Schottelius AJ, Zügel U, Döcke W-D et al. (2010) The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-α pathway of systemic and cutaneous inflammation. J Invest Dermatol 130:481-491